Although SERT expression is reduced in IBD [111] and the observation that SERT−/− rodents suffer from more severe chemically-induced colitis, SSRI administration in animal models seems to play a protective role in gut inflammation. Here, SLC6A4 is linked to inflammatory bowel disease.